Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet

Marie C. Zipser, Ossia M. Eichhoff, Daniel S. Widmer, Natalie C. Schlegel, Nicola L. Schoenewolf, Darrin Stuart, Weihua Liu, Humphrey Gardner, Paul D. Smith, Paolo Nuciforo, Reinhard Dummer, Keith S. Hoek, A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status. Pigment Cell & Melanoma Research. ,vol. 24, pp. 326- 333 ,(2011) , 10.1111/J.1755-148X.2010.00823.X

Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier, Vanna Chiarion-Sileni, Kamil Drucis, Ivana Krajsova, Axel Hauschild, Paul Lorigan, Pascal Wolter, Georgina V Long, Keith Flaherty, Paul Nathan, Antoni Ribas, Anne-Marie Martin, Peng Sun, Wendy Crist, Jeff Legos, Stephen D Rubin, Shonda M Little, Dirk Schadendorf, None, Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib The New England Journal of Medicine. ,vol. 372, pp. 30- 39 ,(2015) , 10.1056/NEJMOA1412690

Julie Caramel, Eftychios Papadogeorgakis, Louise Hill, Gareth J. Browne, Geoffrey Richard, Anne Wierinckx, Gerald Saldanha, Joy Osborne, Peter Hutchinson, Gina Tse, Joël Lachuer, Alain Puisieux, J. Howard Pringle, Stéphane Ansieau, Eugene Tulchinsky, A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. ,vol. 24, pp. 466- 480 ,(2013) , 10.1016/J.CCR.2013.08.018

Frederic Zhentao Li, Amardeep Singh Dhillon, Robin L. Anderson, Grant McArthur, Petranel T. Ferrao, Phenotype switching in melanoma: implications for progression and therapy. Frontiers in Oncology. ,vol. 5, pp. 31- 31 ,(2015) , 10.3389/FONC.2015.00031

Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim, Hanna Cho, Wayne Spevak, Chao Zhang, Ying Zhang, Gaston Habets, Elizabeth A. Burton, Bernice Wong, Garson Tsang, Brian L. West, Ben Powell, Rafe Shellooe, Adhirai Marimuthu, Hoa Nguyen, Kam Y. J. Zhang, Dean R. Artis, Joseph Schlessinger, Fei Su, Brian Higgins, Raman Iyer, Kurt D’Andrea, Astrid Koehler, Michael Stumm, Paul S. Lin, Richard J. Lee, Joseph Grippo, Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, Keith Nolop, Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma Nature. ,vol. 467, pp. 596- 599 ,(2010) , 10.1038/NATURE09454

David Solit, Charles L. Sawyers, How melanomas bypass new therapy Nature. ,vol. 468, pp. 902- 903 ,(2010) , 10.1038/468902A

Matthew W. VanBrocklin, Monique Verhaegen, Maria S. Soengas, Sheri L. Holmen, Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. Cancer Research. ,vol. 69, pp. 1985- 1994 ,(2009) , 10.1158/0008-5472.CAN-08-3934

Georgina V. Long, Carina Fung, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Jessica Hyman, Hamideh Shahheydari, Varsha Tembe, John F. Thompson, Robyn P. Saw, Julie Howle, Nicholas K. Hayward, Peter Johansson, Richard A. Scolyer, Richard F. Kefford, Helen Rizos, Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma Nature Communications. ,vol. 5, pp. 5694- ,(2014) , 10.1038/NCOMMS6694

Poulikos I. Poulikakos, Chao Zhang, Gideon Bollag, Kevan M. Shokat, Neal Rosen, RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature. ,vol. 464, pp. 427- 430 ,(2010) , 10.1038/NATURE08902

Anirudh Prahallad, Chong Sun, Sidong Huang, Federica Di Nicolantonio, Ramon Salazar, Davide Zecchin, Roderick L. Beijersbergen, Alberto Bardelli, René Bernards, Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR Nature. ,vol. 483, pp. 100- 103 ,(2012) , 10.1038/NATURE10868